Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of ...

Merck is acquiring a startup spun out of Yale called Modifi Bio, which has developed a suite of molecules against ...

D r. Uché Blackstock, Adrelia Allen, and Ai-jen Poo gathered at the TIME100 Health Leadership Forum in New York City on Oct. 22 to discuss the need to create equitable access to health care during a ...